US Patent Litigations are now available. Check here

EP2381923

ACERUS PHARMACEUTICALS USA
Application Number
EP09796558A
Filing Date
Dec 21, 2009
Status
Patent Maintained As Amended
May 5, 2023
Grant Date
Jun 7, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP2381923B2 was granted on Jun 7, 2023 by Acerus Pharmaceuticals USA The patent is currently Patent Maintained As Amended.

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionWO2010075266
N/A
OppositionWO9501183
N/A
OppositionUS7112561
N/A
OppositionUS7182226
N/A
OppositionUS7244703
N/A
OppositionUS7405203
N/A
OppositionUS9539302
N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.